Indwelling peritoneal catheters in patients with cirrhosis and refractory ascites

Authors:

Abstract
Background: The prevalence of spontaneous bacterial peritonitis (SBP) in hospitalised cirrhotics with ascites is 10–30%. Treatment for refractory ascites includes paracenteses, transjugular intrahepatic portosystemic shunt or drain placement; the latter is discouraged due to a perceived infection risk.Aim: This study aimed to evaluate the risk of bacterial peritonitis (BP) with peritoneal drains in patients with Child–Pugh classBorCcirrhosis and determine their impact on survival.Methods: We conducted a retrospective review of end‐stage liver disease (ESLD) patients with non‐malignant, refractory ascites who had peritoneal drains placed for ≥3 days atLoyolaUniversity between 1999 and 2009. Cell counts were performed at drain placement and within 72 h.BPwas defined as ascitic polymorphonuclear neutrophils >250/mm3. Univariate analysis assessed the association between demographics, laboratory markers and development ofBP.Kaplan–Meier curve estimates by infection were constructed and survival distributions were compared using log–rank statistic.Results: There were 227 drain placements during the study period. Twenty‐two per cent were diagnosed withBP(12% hadSBPat drain placement; 10% developedBPwithin 72 h). There was no association betweenBPand baseline characteristics. Patients who developedBPwithin 72 h of drain placement had 50% mortality at 5 months compared with 50 months in those without infection (log–rankP≤ 0.003).Conclusion: InESLDpatients who received an indwelling peritoneal catheter, there was 10% risk of developingBPand significant mortality increase. Though placing drains is not the mainstay of treatment for refractory ascites, we confirm the theoretical adverse risk of peritoneal drains on infection and survival in cirrhotics.

This publication has 24 references indexed in Scilit: